Morgan Stanley’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
Morgan Stanley's BCAT Position: Q3 2026 in Review
Morgan Stanley reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 22% in Q3 2026, selling an estimated $12.2M and leaving 2,815,698 shares worth $38.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2507.
Morgan Stanley first reported a position in BCAT in Q3 2020 and has held it in 25 quarters since. The position peaked at $154M in Q1 2023. 119 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.
- Morgan Stanley held 2,815,698 shares of BlackRock Capital Allocation Term Trust worth $38.6M as of Q3 2026.
- Morgan Stanley sold 787,370 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $12.2M.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #2507 holding.
- Morgan Stanley first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 25 quarters since.
- Morgan Stanley's BlackRock Capital Allocation Term Trust position peaked at $154M in Q1 2023.
- 119 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.